Skip to main content
NIH funding notice PAR-19-287

Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Closed on January 28, 2022.

Posted
May 22, 2019
Close date
January 28, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

15 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,099,099 in first-year total cost, median $540,450.

Most frequent study sections

  1. Special Emphasis Panel[ZCA1 RTRB-U (J1)]5
  2. Special Emphasis Panel[ZCA1 RTRB-R (M2)]3
  3. Special Emphasis Panel[ZCA1 RTRB-U (M1)]3
  4. Special Emphasis Panel[ZCA1 RTRB-U (M2)]2
  5. Special Emphasis Panel[ZCA1 SRB-1 (J2)]2

Most frequent institutions

  1. BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
  2. BOSTON UNIVERSITY MEDICAL CAMPUS1
  3. CHILDREN'S HOSP OF PHILADELPHIA1
  4. JOHNS HOPKINS UNIVERSITY1
  5. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
Competing awards under PAR-19-287 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 11U01CA260432-01A1WHITE, RICHARD MARKYANAI, ITAINEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$592,969ZCA1
2022Interrogation of the Impact of Selection on the Evolution of Human Pancreatic Cancer Precursor Lesions1U01CA271273-01A1FERTIG, ELANAKARCHIN, RACHELWOOD, LAURA DELONGJOHNS HOPKINS UNIVERSITY, MD$543,627ZCA1
2022Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers1U01CA264611-01A1GENTLES, ANDREW J.STANFORD UNIVERSITY, CA$539,080ZCA1
2022Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy1U01CA275808-01FINLEY, STACEY DELERIAGRAHAM, NICHOLAS ALEXANDERUNIVERSITY OF SOUTHERN CALIFORNIA, CA$535,157ZCA1
2022Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development1U01CA264583-01A1KADARA, HUMAMWANG, LINGHUAUNIVERSITY OF TX MD ANDERSON CAN CTR, TX$452,903ZCA1
2021Mechanism of estrogen independent proliferation in ER+ breast cancer cells1U01CA264620-01BILD, ANDREA HOPEBECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$596,232ZCA1
2021Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions1U01CA253547-01A1FRAENKEL, ERNESTMESIROV, JILL P.MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$593,964ZCA1
2021Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.1U01CA253472-01A1KORKUT, ANILLIANG, HANMILLS, GORDON B.OREGON HEALTH & SCIENCE UNIVERSITY, OR$540,450ZCA1
2021Clonal Therapy for Pediatric T-cell Acute Lymphoblastic Leukemia1U01CA264610-01YANG, JUN J.YU, JIYANGST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN$528,622ZCA1
2020Multiscale analysis of metabolic inflammation as a driver of breast cancer1U01CA243004-01A1DENIS, GERALD VEMILI, ANDREWMONTI, STEFANOMUTHUSWAMY, SENTHIL KBOSTON UNIVERSITY MEDICAL CAMPUS, MA$593,459ZCA1
2020Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment1U01CA238728-01A1BOSENBERG, MARCUS WMILLER-JENSEN, KATHRYNYALE UNIVERSITY, CT$581,057ZCA1
2020Spatiotemporal modeling of cancer-niche interactions in breast cancer bone metastasis1U01CA253553-01WONG, STEPHEN TCZHANG, XIANGMETHODIST HOSPITAL RESEARCH INSTITUTE, TX$549,065ZCA1
2020Towards rational design of combination therapeutic targets1U01CA243072-01A1TAN, KAITASIAN, SARAH KATHLEENCHILDREN'S HOSP OF PHILADELPHIA, PA$511,423ZCA1
2020Multiscale Computational Models Guided By Emerging Cellular Dynamics Quantification For Predicting Optimum Immune Checkpoint And Targeted Therapy Schedules1U01CA243075-01A1JACKSON, TRACHETTEUNIVERSITY OF MICHIGAN AT ANN ARBOR, MI$497,777ZCA1
2020Systems Approaches to Understanding Subpopulation Heterogeneity in Therapeutic Resistance1U01CA253540-01BROCK, AMYYANKEELOV, THOMAS EUNIVERSITY OF TEXAS AT AUSTIN, TX$443,314ZCA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-19-287: Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) | ScienceDex | ConductScience